Sun Pharmaceutical Industries Ltd. Fundamental & Technical Research, Share Price Today

NSE : SUNPHARMA
NIFTY : Nifty 50
NIFTY SECTOR : Nifty Pharma

About Company

Sun Pharmaceutical Industries Limited is among the largest specialty generic pharmaceutical company and India's top pharmaceutical company. A vertically integrated business and a skilled team enables it to deliver high-quality products, trusted by customers and patients in many countries across the world, at affordable prices. The company manufactures and markets a large basket of pharmaceutical formulations covering a broad spectrum of chronic and acute therapies. It includes generics, branded generics, specialty, complex or difficult to make technology-intensive products, over-the-counter (OTC), antiretrovirals (ARVs), Active Pharmaceutical Ingredients (APIs) and Intermediates. Its broad portfolio of thousands of high quality molecules covers multiple dosage forms, including tablets, capsules, injectables, inhalers, ointments, creams, and liquids.

Market Cap. ₹438,934 Cr.

52 Week - High/Low ₹1,960/1,377

P/E Ratio 139.33

P/B Ratio 18.53

Enterprise Value ₹452,442 Cr.

ROE % 12.05

RSI Value 61.42

EMA 50 1739.72

EMA 200 1711.76

Net Profit 2,858 Cr.

Net Profit 3year growth 239.29 Cr.

Net Profit 3 year (back) 842 Cr.

Debt to Equity 0.47 %

EPS Growth TTM -20.17 %

Current Ratio 3.36 %

100 Day SMA 1,751 Rs.

200 Day SMA 1,773 Rs.

21 Day SMA 1,745 Rs.

50 Day SMA 1,707 Rs.

Book Value 99 Rs.

EV/EBITDA Ratio 75

QoQ EPS Growth 37 %

QoQ Operating Profit Growth 41 %

QoQ Sales Growth 21 %

Sales Latest Quarter 5,985 Cr.

YoY Sales Growth 22 %

Market Cap. ₹438,934 Cr.

52 Week - High/Low ₹1,960/1,377

P/E Ratio 38.39

P/B Ratio 6.89

Enterprise Value ₹425,683 Cr.

ROE % 16.13

RSI Value 61.42

EMA 50 1739.72

EMA 200 1711.76

Net Profit 9,576 Cr.

Net Profit 3year growth 6.2 Cr.

Net Profit 3 year (back) 2,904 Cr.

Debt to Equity 0.04 %

EPS Growth TTM 28.57 %

Current Ratio 2.56 %

100 Day SMA 1,751 Rs.

200 Day SMA 1,773 Rs.

21 Day SMA 1,745 Rs.

50 Day SMA 1,707 Rs.

Book Value 265 Rs.

EV/EBITDA Ratio 26

QoQ EPS Growth -4 %

QoQ Operating Profit Growth -3 %

QoQ Sales Growth 3 %

Sales Latest Quarter 13,437 Cr.

YoY Sales Growth 10 %

Add Parameters

Valuation

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages